Biochip and preparation method thereof, in vitro culture method of oocyte

By using laser scanning of the mixture of cured protein and photosensitizer in the micro chamber of the biochip to form three-dimensional protein bodies, the problem of low oocyte maturation rate in traditional culture methods is solved, and a higher survival and maturation rate is achieved. Provides a more in vivo culture environment.

CN115029239BActive Publication Date: 2024-11-08SHENZHEN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202110251633.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-03-08
Publication Date
2024-11-08
Estimated Expiration
2041-03-08

AI Technical Summary

Technical Problem

When traditional two-dimensional and three-dimensional culture methods are used to cultivate oocytes in vitro, it is difficult to effectively simulate the internal environment, resulting in a low maturity rate of oocytes, and changes in follicle morphology affect localization and signal diffusion, resulting in growth stagnation and meiosis. Impaired ability.

Method used

Using a biochip preparation method, laser layer-by-layer scanning and curing is performed using a mixed solution of protein and photosensitizer in the micro chamber of polydimethylsiloxane, polystyrene and hydrogel materials to form a three-dimensional protein body , providing an environment closer to the body to improve the survival and maturity of oocytes.

Benefits of technology

It improves the survival and maturity rate of oocytes, provides a culture environment closer to the body, enhances the growth and activity of cells, and shows higher survival and maturity rates than traditional three-dimensional culture methods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115029239B_ABST
    Figure CN115029239B_ABST
Patent Text Reader

Abstract

The present invention relates to a biochip and a preparation method thereof, and an in vitro culture method of oocytes. The preparation method of the biochip comprises the following steps: dissolving protein and photosensitizer in water to prepare a mixed solution, in which the concentration of protein is 100 mg / mL to 150 mg / mL, the concentration of photosensitizer is 0.35 w / v% to 0.8 w / v%, and the protein is selected from at least one of albumin, fibronectin and laminin; and adding the mixed solution to a microchamber, and partially solidifying the mixed solution to form a three-dimensional protein body on the bottom wall of the microchamber to prepare a biochip, wherein the material of the side wall of the microchamber is selected from at least one of polydimethylsiloxane, polystyrene and hydrogel. The biochip prepared by the above-mentioned preparation method of the biochip can improve the survival rate and cell activity of cells in vitro, and improve the maturation rate of oocytes.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of biomaterials, and in particular to a biochip and a preparation method thereof, and an in vitro culture method of oocytes. Background Art

[0002] Traditional methods of culturing follicles in vitro to harvest mature oocytes include two-dimensional culture and three-dimensional culture. The two-dimensional culture method is to place the follicles in vessels such as multi-well plates and gelatinized culture dishes for culture. The two-dimensional culture method can only provide the follicles with a flat two-dimensional structure, which is quite different from the three-dimensional environment in the body. In the two-dimensional culture method, the granulosa cells between the oocytes and the culture medium will proliferate and diffuse to the surface of the container. In addition, due to the influence of gravity, the follicles generally lose their shape within 3 to 5 days. This morphological change of the follicles will affect the positioning between follicles, causing the paracrine signals to diffuse and fail to reach the target cells, thereby causing the growth of the oocytes to stagnate, impairing the meiotic ability, and affecting the maturation of the oocytes. Therefore, in order to better simulate the in vivo environment, the three-dimensional culture method has emerged.

[0003] The three-dimensional culture method mainly embeds the follicles in alginate or agarose for culture. The three-dimensional culture method can provide mechanical support for the growth of follicles, meet the three-dimensional space requirements of follicle development, and better imitate the real environment in the body. However, the maturation rate of oocytes cultured by the traditional three-dimensional culture method is low and still needs to be improved. Summary of the invention

[0004] Based on this, it is necessary to provide a biochip and a preparation method thereof that are beneficial to improving the maturation rate of oocytes. In addition, it is also necessary to provide an in vitro culture method of oocytes.

[0005] A method for preparing a biochip comprises the following steps:

[0006] Dissolving the protein and the photosensitizer in water to prepare a mixed solution, wherein the concentration of the protein is 100 mg / mL to 150 mg / mL, the concentration of the photosensitizer is 0.35 w / v% to 0.8 w / v%, and the protein is at least one selected from albumin, fibronectin and laminin; and

[0007] The mixed solution is added into the microchamber of the chip, and the mixed solution is partially solidified to form a three-dimensional protein body on the bottom wall of the microchamber to prepare a biochip, wherein the material of the side wall of the microchamber is selected from at least one of polydimethylsiloxane, polystyrene and hydrogel.

[0008] The biochip prepared according to the preparation method is provided with a three-dimensional protein body in a microchamber whose side wall material is selected from at least one of polydimethylsiloxane, polystyrene and hydrogel, and the three-dimensional protein body is polymerized from a mixed solution of protein with a concentration of 100mg / mL to 150mg / mL and a photosensitizer with a concentration of 0.35w / v% to 0.8w / v%, so that the biochip can provide an environment closer to the body for cells cultured in vitro, thereby improving the survival rate and cell activity of cells cultured in vitro. When the above biochip is applied to the in vitro culture of oocytes, the survival rate and maturation rate of oocytes can be improved.

[0009] In one embodiment, the albumin is selected from at least one of bovine serum albumin, human serum albumin, human recombinant serum albumin, goat serum albumin and rabbit serum albumin;

[0010] And / or, the photosensitizer is sodium bengal, methylene blue or rose bengal.

[0011] In one embodiment, the mixed liquid is partially solidified by using a laser, wherein the wavelength of the laser is 730nm to 850nm, and the energy of the laser is 24mW to 80mW.

[0012] In one embodiment, the albumin is further labeled with fluorescein, and the fluorescein is selected from at least one of FITC and PE.

[0013] In one embodiment, in the operation of partially solidifying the mixed liquid, a laser is used to scan the local mixed liquid layer by layer to locally solidify the mixed liquid, wherein during the layer-by-layer scanning, the scanning cross sections of each layer are parallel to each other, and the area of ​​the scanning cross section of each layer is 2512 μm 2 ~44986.41μm 2 The spacing between the scanning sections of two adjacent layers is 0.20 μm to 100 μm.

[0014] In one of the embodiments, the operation of using a laser to scan the local mixed liquid layer by layer to locally solidify the mixed liquid also includes providing an oxygen environment so that the laser scans the mixed liquid layer by layer in the oxygen environment, and the oxygen partial pressure of the oxygen environment is 25kPa~30kPa and the volume concentration of oxygen is 20%~80%.

[0015] A biochip, comprising:

[0016] A microchamber, wherein the microchamber has a chamber wall, wherein the chamber wall includes a bottom wall and a side wall connected to the bottom wall, and a material of the side wall is selected from at least one of polydimethylsiloxane, polystyrene and hydrogel; and

[0017] The three-dimensional protein body is located on the bottom wall of the microchamber and is separated from the side wall of the microchamber. The three-dimensional protein body is formed by local solidification of a mixed liquid located in the microchamber. The mixed liquid includes protein, a photosensitizer and water. In the mixed liquid, the concentration of the protein is 100 mg / mL to 150 mg / mL, the concentration of the photosensitizer is 0.15 w / v% to 0.8 w / v%, and the protein is selected from at least one of albumin, fibronectin and laminin.

[0018] In one embodiment, there are multiple three-dimensional protein bodies in the microchamber, and the multiple three-dimensional protein bodies are spaced apart from each other.

[0019] In one embodiment, the three-dimensional protein body is columnar, and the height of the three-dimensional protein body is 1 μm to 600 μm.

[0020] An in vitro culture method of oocytes comprises the following steps:

[0021] The follicles are inoculated into the biochip prepared by the above-mentioned biochip preparation method or the above-mentioned biochip for culture. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 is a schematic structural diagram of a biochip according to one embodiment;

[0023] Figure 2 is a scanning electron microscope image of the biochip of Example 1;

[0024] Figure 3 for Figure 2 A local scanning electron microscope image of the biochip;

[0025] Figure 4 for Figure 2 Another partial scanning electron microscope image of the biochip;

[0026] Figure 5 This is a confocal electron microscope image of a three-dimensional protein body formed after cross-linking during the preparation of the biochip in Example 1;

[0027] Figure 6 The image of the oocyte cultured in vitro by the biochip of Example 1 under a confocal microscope;

[0028] Figure 7 The image of the oocyte cultured in vitro by the biochip of Example 1 under an inverted microscope;

[0029] Figure 8 The image of the oocyte cultured in vitro by the biochip of Example 2 under an inverted microscope;

[0030] Fig. 9This is an image of oocytes cultured in vitro on the biochip of Example 3 under an inverted microscope.

[0031] Reference numerals:

[0032] 10. Biochip; 20. Cell; 110. Substrate; 130. Microchamber; 150. Three-dimensional proteosome. DETAILED DESCRIPTION

[0033] In order to facilitate the understanding of the present invention, the present invention will be described more fully below, and the present invention can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the disclosure of the present invention more thorough and comprehensive.

[0034] It should be noted that when an element is described as being "fixed to" another element, it may be directly on the other element, or one or more centered elements may exist therebetween. When an element is described as being "connected to" another element, it may be directly connected to the other element, or one or more centered elements may exist therebetween. When the terms "vertical", "horizontal", "left", "right", "upper", "lower", "inner", "outer", "bottom" and the like are used to indicate an orientation or positional relationship, it is based on the orientation or positional relationship shown in the accompanying drawings, only for the convenience of description, and does not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as a limitation on the present application.

[0035] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used in the specification of the present invention herein are only for the purpose of describing specific embodiments and are not intended to limit the present invention.

[0036] An embodiment of the present invention provides a method for preparing a biochip, the method comprising steps a to c, specifically:

[0037] Step a: Preparation of microchambers.

[0038] Specifically, the microchamber has a bottom wall and a side wall connected to the bottom wall, and the material of the side wall is selected from at least one of polydimethylsiloxane, polystyrene and hydrogel; the material of the bottom wall is a transparent material, such as glass or transparent resin. In this embodiment, the material of the side wall of the microchamber is polydimethylsiloxane formed by polymerization of polydimethylsiloxane monomers.

[0039] Optionally, the entire microchamber is integrally formed by polymerizing polydimethylsiloxane monomers. Specifically, the microchamber is prepared by a molding method. The molding method is a method of obtaining a mold by using photoresist or the like, and solidifying a liquid polymer monomer on the mold to obtain a microstructure.

[0040] In an optional specific example, the steps of preparing the microchamber include: designing an acrylic mold according to the shape of the microchamber to be obtained, then covering the acrylic mold with polydimethylsiloxane monomer and curing agent, using a vacuum pump to draw negative pressure and then heat and cure to prepare a negative mold; pouring a mixed prepolymer containing polydimethylsiloxane monomer on the negative mold, and then curing the prepolymer; then using anhydrous ethanol to separate and prepare the side wall of the microchamber; then connecting the side wall of the microchamber to a cover glass to form a microchamber with an opening that can hold a culture medium to culture cells. Of course, the prepolymer also includes a curing agent that polymerizes the polydimethylsiloxane monomer.

[0041] By using a prepolymer containing polydimethylsiloxane monomer as a material for preparing a microchamber, a polydimethylsiloxane microchamber (PDMS microchamber) can be prepared. It is understood that in other embodiments, the monomer of the prepolymer in the process of preparing the microchamber is not limited to the polydimethylsiloxane monomer, and the corresponding monomer can also be selected according to the material of the microchamber to be prepared.

[0042] In this embodiment, there are multiple microchambers spaced apart from each other. Specifically, the microchamber is in the shape of a hollow cylinder, the inner diameter of the microchamber is 300 μm to 100 μm, and the depth of the microchamber is 300 μm to 1000 μm. It is understood that in other embodiments, the number of microchambers may be one; the shape of the microchamber is not limited to the hollow cylinder, but may be other shapes. The size of the microchamber is also not limited to the above, and may be adjusted according to actual needs.

[0043] Step b: Dissolve the protein and photosensitizer in water to prepare a mixed solution.

[0044] Specifically, in the mixed solution, the concentration of protein is 100mg / mL to 150mg / mL, and the concentration of photosensitizer is 0.35w / v% to 0.8w / v%. If the concentration of protein is too high and the concentration of photosensitizer is too low, it is difficult to form a three-dimensional protein body with a three-dimensional structure. If the concentration of protein is too low and the concentration of photosensitizer is too high, the biological properties of the three-dimensional protein body cannot be achieved. The concentrations of protein and photosensitizer in the mixed solution of this embodiment are appropriate, and it is easy to prepare a three-dimensional protein body with a preset structural shape on the bottom of the microchamber, and the biological function of the three-dimensional protein body can be maintained. Specifically, the protein is selected from at least one of albumin, fibronectin and laminin.

[0045] In an optional specific example, the concentration of the protein is 100 mg / mL, 105 mg / mL, 120 mg / mL, 125 mg / mL, 130 mg / mL, 145 mg / mL, 140 mg / mL, 145 mg / mL or 150 mg / mL, and the concentration of the photosensitizer is 0.35 w / v%, 0.4 w / v%, 0.45 w / v%, 0.5 w / v%, 0.6 w / v%, 0.65 w / v%, 0.7 w / v% or 0.8 w / v%. Further, the concentration of the protein is 100 mg / mL to 120 mg / mL, and the concentration of the photosensitizer is 0.4 w / v% to 0.8 w / v%. Further, the concentration of the protein is 100 mg / mL to 110 mg / mL, and the concentration of the photosensitizer is 0.45 w / v% to 0.7 w / v%. It should be noted that w / v% represents the mass-to-volume ratio. For example, the final concentration of the photosensitizer in the first mixed solution is 0.04 w / v%, which means that the final concentration of the photosensitizer in the first mixed solution is 0.4 g / L.

[0046] In one embodiment, the albumin is selected from at least one of bovine serum albumin (BSA), human serum albumin (HSA), human recombinant serum albumin, goat serum albumin and rabbit serum albumin. The photosensitizer is sodium bengal sodium salt (RB), methylene blue or rose bengal. The albumin and the photosensitizer are solidified under the action of laser to form a three-dimensional protein body. Of course, in other embodiments, the photosensitizer is not limited to the above, and can also be other photosensitizers.

[0047] In one embodiment, the albumin is also labeled with fluorescein. Further, the fluorescein is selected from at least one of FITC (fluorescein isothiocyanate) and PE (phycoerythrin). Labeling the albumin with fluorescein can further improve the smoothness and hardness of the surface of the solidified three-dimensional protein body and the stability in the microchamber.

[0048] Step c: adding the mixed solution prepared in step b to the microchamber prepared in step a, and partially solidifying the mixed solution to form a three-dimensional protein body on the surface of the bottom wall of the microchamber to prepare a biochip.

[0049] Specifically, a laser is used to locally solidify the mixed liquid in the microchamber to form a three-dimensional protein body. The mixed liquid contains albumin and a photosensitizer. A laser is used to pass through the bottom wall of the microchamber and scan the local mixed liquid layer by layer. The mixed liquid irradiated by the laser gradually solidifies on the surface of the bottom wall of the microchamber to form a three-dimensional protein body, while the mixed liquid not irradiated by the laser still exists in a liquid form, thereby achieving local solidification of the mixed liquid. Layer-by-layer scanning refers to scanning from one direction to another, for example, passing the laser through the microchamber and starting to scan from the side of the mixed liquid close to the bottom wall of the microchamber, then moving upward a certain distance, and continuing to scan the next layer of liquid surface, and the mixed liquid gradually solidifies to form a three-dimensional protein body.

[0050] More specifically, in the operation of using laser to scan the local mixed solution layer by layer to locally solidify the mixed solution to form a three-dimensional protein body, when scanning layer by layer, the scanning cross sections of each layer are parallel to each other, and the area of ​​the scanning cross section of each layer is 2512 μm 2 ~44986.41μm 2 The spacing between two adjacent scanning sections is 0.20 μm to 1.00 μm. Scanning layer by layer makes the formation process of the three-dimensional protein body more stable, and the three-dimensional protein body obtained has stronger hardness.

[0051] In this embodiment, each scanning cross section is circular. Of course, in other embodiments, each scanning cross section can also be any shape such as rectangular or triangular.

[0052] In some embodiments, in the operation of using laser to scan the local mixed liquid layer by layer to locally solidify the mixed liquid to form a three-dimensional protein body, the laser is divided into multiple laser units, and the multiple laser units simultaneously scan the mixed liquid layer by layer to simultaneously form multiple three-dimensional protein bodies in the mixed liquid, thereby easily realizing mass production. In an optional specific example, the laser is divided into 64 laser units, and the area of ​​the scanning cross section of each laser unit is 39.25 μm 2 The laser passes through the bottom wall of the microchamber, first scanning the mixed liquid near the bottom wall of the microchamber, then moves upward 0.5μm, and continues to scan the next layer of liquid surface. The total moving distance is 10μm. The mixed liquid gradually solidifies to form an 8×8 microcolumn array, where the microcolumns in the microcolumn array are cylindrical and have a size of Φ5×5μm.

[0053] In some embodiments, the operation of using laser to scan the local mixed liquid layer by layer to locally solidify the mixed liquid to form a three-dimensional protein body also includes providing an oxygen environment so that the laser scans the mixed liquid layer by layer in the oxygen environment, and the oxygen partial pressure of the oxygen environment is 25kPa-30kPa, and the volume concentration of oxygen is 20%-80%. The albumin in the mixed liquid, the photosensitizer, and the oxygen free radicals in the surrounding oxygen environment covalently recombine to form a three-dimensional protein body, and the internal structure of the three-dimensional protein body is more tightly cross-linked, so that the surface of the prepared three-dimensional protein body is smooth and has high hardness. Specifically, the fluorescein-labeled albumin and the photosensitizer undergo a cross-linking reaction under the action of a laser. The photosensitizer is excited by a laser of a specific wavelength (730nm~850nm) and light energy (24mW~80mW), and the photosensitizer returns an emission light, which further excites the fluorescein on the fluorescein-labeled albumin, causing the fluorescein-labeled albumin, the photosensitizer, and the oxygen free radicals in the surrounding oxygen environment to covalently recombine to form a three-dimensional protein body. The internal structure of this three-dimensional protein body is more tightly cross-linked, so that the surface of the prepared three-dimensional protein body is smooth and has high hardness.

[0054] In this embodiment, in the operation of using laser to scan the local mixed liquid layer by layer to locally solidify the mixed liquid to form a three-dimensional protein body, the wavelength of the laser is 800nm ​​and the energy of the laser is 40mW to 50mW. Using a laser with a wavelength of 800nm ​​and an energy of 40mW to 50mW can more easily successfully produce the desired microcolumns, and can also make the produced microcolumns highly stable and not easy to collapse. Further, the wavelength of the laser is 800nm ​​and the energy of the laser is 43mW.

[0055] In some embodiments, the process of using laser to scan the local mixed liquid layer by layer to solidify the mixed liquid locally to form a three-dimensional protein body also includes providing a certain humidity condition to further improve the smoothness and hardness of the prepared three-dimensional protein body. Optionally, the humidity is 45% to 60%.

[0056] The above-mentioned method for preparing the biochip has at least the following advantages:

[0057] (1) Albumin and photosensitizer are dissolved in an aqueous solution at a certain concentration ratio to obtain a mixed solution, which is added to the microchamber, and the local mixed solution is scanned layer by layer by excitation to solidify the mixed solution locally to form a three-dimensional protein body. The three-dimensional protein body formed by this method has a stable structure, and is tightly bound to polydimethylsiloxane with strong binding force, and can be firmly located on the bottom wall of the microchamber made of polydimethylsiloxane silane.

[0058] (2) Furthermore, the albumin is also labeled with fluorescein. The fluorescein-labeled albumin is mixed with a photosensitizer to undergo a cross-linking reaction. Under the conditions of an oxygen partial pressure of 25 kPa to 30 kPa and an oxygen volume concentration of 20% to 80%, a laser is used to scan layer by layer. The laser excites the photosensitizer, and the photosensitizer returns an emission light. The emission light further excites the fluorescein on the fluorescein-labeled albumin, causing the fluorescein-labeled albumin, the photosensitizer and the surrounding oxygen free radicals to covalently recombine. The prepared three-dimensional protein body has small pores and high hardness, so that the three-dimensional protein body can be more stably arranged on the hydrogel membrane.

[0059] (3) The preparation process is simple, and three-dimensional patterns of different shapes can be easily formed by adjusting the laser irradiation path, which can be mass-produced.

[0060] (4) Compared with the three-dimensional culture system using alginate, the survival rate, maturation rate and fertilization rate of oocytes cultured in vitro using this biochip are high.

[0061] See also Figure 1In one embodiment of the present invention, a biochip 10 is provided, which includes a substrate 110, a microchamber 130 located on the substrate 110, and a three-dimensional protein body 150 located in the microchamber 130. The substrate 110 provides support for the microchamber 130. The microchamber 130 provides support for the three-dimensional protein body 150 and can hold a culture solution for culturing cells. The microchamber 130 has a chamber wall, which includes a bottom wall and a side wall connected to the bottom wall; the three-dimensional protein body 150 is located on the bottom wall of the microchamber 130 and is spaced from the side wall of the microchamber 130, and is formed by local solidification of the mixed solution located in the microchamber 130. Among them, the preparation of the microchamber 130 is also as described above, and the parameters such as the composition of the mixed solution, the selection of the laser, and the scanning method of the laser in the preparation process of the three-dimensional protein body 150 are as described above, and will not be repeated here. The biochip 10 can be used for in vitro culture of cells 20. Optionally, the biochip 10 can be used for in vitro culture of oocytes.

[0062] Specifically, the three-dimensional protein bodies 150 are located on the surface of the bottom wall of the microchamber 130; there are multiple three-dimensional protein bodies 150 in the microchamber 130 and they are spaced apart from each other. Furthermore, the multiple three-dimensional protein bodies 150 in the microchamber 130 can form a certain shape, for example, a shape adapted to cell growth and development, so as to be closer to the environment of the cell 20 in the body.

[0063] The material of the side wall of the micro chamber 130 is at least one of polydimethylsiloxane, polystyrene and hydrogel; the material of the bottom wall is a transparent material, such as glass or transparent resin. In this embodiment, the material of the side wall of the micro chamber 130 is polydimethylsiloxane (PDMS) polymerized from polydimethylsiloxane monomers; the material of the bottom wall is glass.

[0064] In one embodiment, the material of the microchamber 130 is selected from at least one of polydimethylsiloxane, polystyrene and hydrogel. Optionally, the material of the microchamber 130 is polydimethylsiloxane obtained by polymerizing polydimethylsiloxane monomers.

[0065] Optionally, the height of the three-dimensional protein body is 1 μm to 600 μm. Further, the height of the three-dimensional protein body is 5 μm to 15 μm. According to the above setting of the height of the three-dimensional protein body, it can be more suitable for culturing oocytes.

[0066] In an optional specific example, the height of the three-dimensional protein body 150 is 10 μm; the microchamber 130 is a hollow cylindrical shape, the inner diameter of the microchamber 130 is 500 μm, and the depth of the microchamber 130 is 500 μm. Setting the height of the three-dimensional protein body 150 to 10 μm can provide a relatively soft matrix environment for the oocyte, which promotes the oocyte to withstand. Setting the inner diameter of the microchamber 130 to 500 μm and the depth of the microchamber 130 to 500 μm can smoothly accommodate the size of the oocyte and co-culture the surrounding granulosa cells at the same time, providing sufficient growth factors for the oocyte. Of course, in other embodiments, the height of the three-dimensional protein body 150, the shape of the microchamber 130 and the size of the microchamber 130 can be adjusted according to the type of cells cultured and the purpose of the study.

[0067] In the illustrated embodiment, the microchamber 130 is located in the dish-shaped substrate 110, and the microchambers 130 are multiple and independently spaced from each other. It is understood that in some other embodiments, adjacent microchambers 130 can be connected, for example, multiple microchambers 130 are integrally formed; the shape of the substrate 110 is not limited to the above, and can also be other shapes.

[0068] In some embodiments, a three-dimensional protein body 150 is further disposed on the side wall of the microchamber 130. Specifically, there are a plurality of three-dimensional protein bodies 150 on the side wall, and the plurality of three-dimensional protein bodies 150 are disposed on the side wall of the microchamber 130 at intervals.

[0069] It is understood that in some embodiments, the substrate 110 can be omitted. When the substrate 110 is omitted, there is one microchamber 130 or there are multiple microchambers 130 and adjacent microchambers 130 are connected. In some embodiments, the bottom wall of the microchamber 130 can be omitted. When the bottom wall of the microchamber 130 is omitted, the microchamber 130 uses the substrate 110 as the bottom, that is, the side wall of the microchamber 130 and the substrate 110 constitute the microchamber 130.

[0070] The biochip 10 uses a microchamber made of PDMS material combined with a three-dimensional protein body, which can provide a microenvironment closer to the body for cell growth and improve the survival rate and quality of cells in vitro.

[0071] One embodiment of the present invention also provides an application of the above biochip in preparing mature oocytes in vitro. In this application, by utilizing the advantages of the above biochip, oocytes develop in follicles, so that the number of mature oocytes obtained by culturing follicles in vitro can be larger and the activity can be better.

[0072] In addition, an embodiment of the present invention also provides an in vitro culture method of oocytes, which utilizes the above biochip to culture follicles in vitro to harvest mature oocytes. Specifically, the method comprises the following steps: inoculating follicles into the above biochip for culture.

[0073] The above-mentioned in vitro culture method of oocytes utilizes the above-mentioned biochip to culture follicles. It has been verified that the above-mentioned culture method has high survival rate, high maturation rate and high fertilization rate of oocytes. Specific embodiments

[0075] The following is described in detail in conjunction with specific embodiments. The following embodiments do not include other components except inevitable impurities unless otherwise specified. The reagents and instruments used in the embodiments are conventionally selected in the art unless otherwise specified. The experimental methods for which specific conditions are not specified in the embodiments are implemented according to conventional conditions, such as the conditions described in the literature, books, or the methods recommended by the manufacturer. Not specifically specified, the following materials used: fetal bovine serum (BSA) is provided by life science, product number 0332. Fetal bovine serum labeled with fluorescein isothiocyanate (FITC-BSA) is provided by nanocs, product number BS1-FC-1. The photosensitizer is sodium bengal salt (RB) and the photosensitizer is provided by sigma, product number 330000. Nanohydrogel (sodium alginate hydrogel of Example 5) is provided by sigma, product number 53747.

[0076] Example 1

[0077] (1) BSA and RB photosensitizer were dissolved in a certain amount of water to obtain a mixed solution, wherein the concentration of BSA in the mixed solution was 100 mg / mL and the concentration of RB photosensitizer was 0.6 w / v%.

[0078] (2) Covering the acrylic template designed according to the shape of the microchamber to be obtained with polydimethylsiloxane monomer and curing agent (Dow Corning Sylgard 184 silicone), using a vacuum pump to draw negative pressure and then heat and cure to prepare a negative mold; pouring the mixed prepolymer containing polydimethylsiloxane monomer on the negative mold, and then curing the prepolymer. Using anhydrous ethanol for separation; connecting the side wall of the manufactured microchamber and the cover glass, using the cover glass as the bottom and polydimethylsiloxane as the side wall, to manufacture a microchamber.

[0079] (3) 1 mL of the mixed solution obtained in step (1) is added dropwise to the microchamber obtained in step (2) through a pipette. A 40× oil objective lens is used, and a two-photon exciter is used to emit a laser, which passes through the bottom wall of the microchamber and scans the mixed solution layer by layer to solidify the mixed solution. The wavelength of the laser is set to 800 nm, the energy is 43 mW, and the area of ​​the cross section scanned by each laser beam is 39.25 μm 2. The laser passes through the bottom wall of the microchamber into the mixed liquid, and scans upward layer by layer from the surface of the bottom wall of the microchamber (the bottom of the mixed liquid). After scanning one layer, it moves upward 0.5μm and continues to scan the next layer of liquid surface. The total movement distance is 10μm. The mixed liquid cross-links and solidifies to form a micron-scale columnar structure, that is, a three-dimensional protein body. In this embodiment, a 9×9 array is formed in the microchamber, and the three-dimensional protein body in the array has a diameter of 5μm and a height of 10μm; the formed three-dimensional protein body is shown in the local picture under a confocal microscope. Figure 5 shown.

[0080] (4) The unreacted mixed solution in the microchamber is removed to obtain a biochip.

[0081] Example 1 The scanning electron microscope image of the biochip is as follows Figure 2 As shown, the local enlarged picture is as follows Figure 3-4 The above method can form stable three-dimensional protein bodies in microchambers.

[0082] Example 2

[0083] The preparation method of the biochip of Example 2 is substantially the same as that of Example 1, except that the concentration of BSA in the mixed solution of Example 2 is 100 mg / mL, and the concentration of RB photosensitizer is 0.4 w / v%.

[0084] Example 3

[0085] The preparation method of the biochip of Example 3 is substantially the same as that of Example 1, except that the concentration of BSA in the mixed solution of Example 3 is 100 mg / mL, and the concentration of RB photosensitizer is 0.8 w / v%.

[0086] Example 4

[0087] The preparation method of the biochip of Example 4 is substantially the same as that of Example 1, except that the mixed solution of Example 4 is composed of fluorescein-labeled fetal bovine serum (FITC-BSA), RB photosensitizer and water, the concentration of FITC-BSA in the mixed solution of Example 4 is 100 mg / mL, and the concentration of RB photosensitizer is 0.4 w / v%; and the steps of preparing the three-dimensional proteosome are as follows:

[0088] 1 mL of the prepared mixed solution was added dropwise to the prepared microchamber through a pipette, and the microchamber was placed in a high oxygen sealed chamber, and the oxygen partial pressure, oxygen concentration, and humidity in the high oxygen sealed chamber were set to 25 kPa, 75%, and 60%. A 40× oily objective lens was used, and a two-photon exciter was used to emit a laser, which passed through the bottom wall of the microchamber and scanned the mixed solution layer by layer to solidify the mixed solution. The wavelength of the laser was set to 800 nm, the energy was 40 mW, and the area of ​​the cross section scanned by each laser beam was 39.24 μm 2. The laser passes through the bottom wall of the microchamber into the mixed liquid, and scans upward layer by layer from the surface of the bottom wall of the microchamber (the bottom of the mixed liquid). After scanning one layer, it moves upward 0.5μm and continues to scan the next layer of liquid surface. The total moving distance is 10μm. The mixed liquid cross-links and solidifies to form a micron-scale columnar structure, that is, a three-dimensional protein body. In this embodiment, a 9×9 array is formed in the microchamber, and the length, width and height of the three-dimensional protein body in the array are Φ5μm×5μm×10μm.

[0089] Example 5

[0090] The preparation method of the biochip of Example 5 is substantially the same as that of Example 1, except that the material of the side walls of the microchambers of Example 5 is sodium alginate hydrogel.

[0091] Comparative Example 1

[0092] The preparation method of the biochip of Comparative Example 1 is substantially the same as that of Example 1, except that the concentration of BSA in the mixed solution of Comparative Example 1 is 80 mg / mL, and the concentration of RB photosensitizer is 0.6 w / v%.

[0093] Comparative Example 2

[0094] The preparation method of the biochip of Comparative Example 2 is substantially the same as that of Example 1, except that the concentration of BSA in the mixed solution of Comparative Example 2 is 160 mg / mL, and the concentration of RB photosensitizer is 0.6 w / v%.

[0095] Comparative Example 3

[0096] The preparation method of the biochip of Comparative Example 3 is substantially the same as that of Example 1, except that the steps of preparing the mixed solution and preparing the three-dimensional proteosome in the microchamber are omitted in Comparative Example 3. That is, compared with the biochip of Example 1, there is no three-dimensional proteosome in the microchamber on the biochip of Comparative Example 3.

[0097] test

[0098] The biochips of the embodiments and comparative examples were used to culture follicles to detect their performance.

[0099] Specifically, the steps of culturing follicle cells in each biochip include:

[0100] The BABL / c female mice were injected intraperitoneally with 10 IU PMSG / mouse during diestrus and 10 IU HCG / mouse 48 hrs later. After 16 hours, the rats were killed by dislocation of the neck, and the back skin and muscle layer were cut open after disinfection with 70% ethanol. The ovaries, fallopian tubes, and a small section of the uterus were peeled off and placed in M2 operating medium preheated at 37°C. The excess fat tissue was removed under a stereomicroscope using a No. 5 syringe needle, and the fallopian tubes were separated. After washing 3 times, they were moved to new M2 culture medium, and the enlarged ampulla of the fallopian tube was found and punctured with a needle. The cumulus oocyte complex then gushed out. The cumulus oocyte complex was moved to a microchamber preheated at 37°C with an egg suction needle, and the maturation state and number of oocyte nuclei were observed and recorded under an inverted microscope. The oocyte maturation rate was counted after 18 hours. In the control group, 20 μL of culture medium was added to the culture dish using a pipette gun to make a two-dimensional culture droplet, and mineral oil was covered on the surface of the droplet. The results are shown in Table 1.

[0101] The images of the oocyte cultured in vitro on the biochip prepared in Example 1 under a confocal microscope and an inverted microscope are as follows: Figure 6 and Figure 7 As shown; the image of the oocyte cultured in vitro by the biochip of Example 2 under an inverted microscope is as shown Figure 8 As shown; the image of the oocyte cultured in vitro by the biochip of Example 3 under an inverted microscope is as shown Fig. 9 shown.

[0102] Table 1

[0103]

[0104]

[0105] As shown in Table 1, the use of BSA concentration of 100mg / mL to 150mg / mL and RB photosensitizer concentration of 0.35w / v% to 0.8w / v% can make the maturation rate of oocytes higher. When the concentration of BSA is 120mg / mL and the concentration of RB photosensitizer is 0.4w / v%, the maturation rate of oocytes is 72%, which is much higher than the maturation rate of oocytes cultured in two dimensions (control group); the maturation rate of follicles cultured in sodium alginate hydrogel is 56%.

[0106] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0107] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.

Claims

1. A method for preparing a biochip, characterized in that: The steps are: Dissolving the protein and the photosensitizer in water to prepare a mixed solution, wherein the concentration of the protein is 100 mg / mL, the concentration of the photosensitizer is 0.6 w / v%, and the protein is albumin; and Adding the mixed solution into a microchamber of a chip, and partially solidifying the mixed solution to form a three-dimensional protein body on the bottom wall of the microchamber, to prepare a biochip, wherein the material of the side wall of the microchamber is polydimethylsiloxane; The mixed liquid is partially solidified by using a laser, wherein the wavelength of the laser is 800 nm and the energy of the laser is 43 mW; In the operation of partially solidifying the mixed liquid, the laser is used to scan the local mixed liquid layer by layer to locally solidify the mixed liquid, wherein when scanning layer by layer, the scanning cross sections of each layer are parallel to each other, and the area of ​​the scanning cross section of each layer is 39.25 μm 2 , the spacing between the scanning sections of two adjacent layers is 0.5 μm; A 9×9 array was formed in the microchamber, and the three-dimensional protein bodies in the array were 5 μm in diameter and 10 μm in height; There are a plurality of three-dimensional protein bodies in the microchamber, and the plurality of three-dimensional protein bodies are spaced apart from each other.

2. The method for preparing a biochip according to claim 1, characterized in that: The albumin is selected from at least one of bovine serum albumin, human serum albumin, human recombinant serum albumin, goat serum albumin and rabbit serum albumin; And / or, the photosensitizer is sodium bengal, methylene blue or rose bengal.

3. The method for preparing a biochip according to claim 1, characterized in that: The albumin is also labeled with fluorescein, and the fluorescein is selected from at least one of FITC and PE.

4. A biochip prepared by the preparation method according to any one of claims 1 to 3.

5. An in vitro culture method of oocytes, characterized in that: The following steps are involved: The follicles are inoculated into the biochip prepared by the method for preparing a biochip according to any one of claims 1 to 3 for culture.